原発性肺癌におけるCA19-9の意義 : 血中濃度と組織内局在の検討
書誌事項
- タイトル別名
-
- The carbohydrate antigen 19-9 in serum and tissue of patients with lung cancer.
- 原発性肺癌におけるCA 19‐9の意義 血中濃度と組織内局在の検討
- 血中濃度と組織内局在の検討
この論文をさがす
説明
The 19-9 monoclonal antibody, prepared by Koprowski et al., reacts with a carbohydrate antigenic determinant (CA 19-9) which has been identified as a sialylated lacto-Nfucopentaose II. CA19-9 has been known to be a useful tumor marker for gastrointestinal carcinoma, especially pancreatic cancer.<BR>The authors investigated the significance of this antigen for lung cancer. We measured serum CA 19-9 concentration in 56 patients with lung cancer by a forward sandwich type radioimmunometric assay (cut-off value 37 U/ml), and immunostained the antigen in 32 lung cancer tissue by an immunoperoxidase assay.<BR>The positive rate of serum CA 19-9 concentration was 16%, lower than that of carcinoembryonic antigen (CEA). The concentration of the antigen was markedly increased in patients with bronchial gland type adenocarcinoma, and strongly stained in cancer tissue.
収録刊行物
-
- 肺癌
-
肺癌 28 (1), 11-17, 1988
特定非営利活動法人 日本肺癌学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001204678520832
-
- NII論文ID
- 110003131846
-
- NII書誌ID
- AN00203978
-
- ISSN
- 13489992
- 03869628
- http://id.crossref.org/issn/03869628
-
- HANDLE
- 10559/14665
-
- 本文言語コード
- ja
-
- 資料種別
- journal article
-
- データソース種別
-
- JaLC
- IRDB
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可